Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for cancer

T J Kipps1

  • 1Department of Medicine, University of California, San Diego, La Jolla 92093-0663.

Journal of Hematotherapy
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

New cancer treatments leverage molecular insights into neoplasia and immune system activation. The 21st century promises advancements in gene therapy and molecular pharmacology for cancer care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL.

Leukemia·2017
Same author

Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells.

Leukemia·2017
Same author

Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells.

Leukemia·2017
Same author

Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia.

Leukemia·2017
Same author

Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib.

Leukemia·2016
Same author

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.

Leukemia·2016
Same journal

Comparative evaluation of procedures with a Baxter CS-3000 cell separator for collecting peripheral blood cells from children.

Journal of hematotherapy·1999
Same journal

Graft engineering of G-CSF-mobilized allogeneic leukapheresis products by counterflow centrifugal elutriation after CD34 column adsorption.

Journal of hematotherapy·1999
Same journal

Serum granulocyte colony-stimulating factor kinetics in children receiving intense chemotherapy with or without stem cell support.

Journal of hematotherapy·1999
Same journal

Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92.

Journal of hematotherapy·1999
Same journal

The differentiating effect of retinoic acid and vincristine on acute myeloid leukemia.

Journal of hematotherapy·1999
Same journal

Comparison of T-cell-depleted BMT and PBPCT with respect to chimerism, graft rejection, and leukemic relapse.

Journal of hematotherapy·1999
See all related articles

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Understanding the molecular underpinnings of neoplasia has advanced significantly.
  • Mechanisms of immune system activation are increasingly understood.
  • These advances offer novel therapeutic strategies for cancer treatment.

Purpose of the Study:

  • To review recent developments in cancer treatment.
  • To highlight potential clinical applications emerging by the early 21st century.
  • To discuss the prospective era of gene therapy and molecular pharmacology in medicine.

Main Methods:

  • Review of recent scientific literature and clinical advancements.
  • Analysis of emerging molecular and immunological approaches to cancer.
  • Projection of future clinical utility for novel therapies.

Related Experiment Videos

Main Results:

  • Identification of key molecular targets in neoplasia.
  • Elucidation of immune system activation pathways relevant to cancer.
  • Emerging therapeutic modalities poised for clinical integration.

Conclusions:

  • The 21st century is anticipated to be transformative for cancer medicine.
  • Gene therapy and molecular pharmacology represent key future directions.
  • Integration of molecular and immunological insights will drive therapeutic innovation.